Publications by authors named "Li-Nan Deng"
Curr Med Sci
February 2022
Article Synopsis
- The study examines the effectiveness of decitabine for treating myelodysplastic syndrome (MDS) and identifies factors that predict patient response and survival.
- Out of 94 MDS patients analyzed, 62% responded to decitabine therapy, with varying levels of remission observed, and those who responded had a significantly longer overall survival than non-responders.
- Platelet doubling after the first cycle of decitabine therapy emerged as a strong predictor of both response to treatment and overall survival in MDS patients.
